Policy # Policy Title Print View
VP-0008 Aloxi® (palonosetron) (Intravenous)
VP-0036 Emend® (fosaprepitant dimeglumine) (Intravenous)
VP-0043 Faslodex® (fulvestrant) (Intramuscular)
VP-0071 Immune Globulins (immunoglobulin) (Intravenous)
VP-0089 Nplate™ (romiplostim) (Subcutaneous)
VP-0161 Zaltrap® (ziv-aflibercept) (Intravenous)
VP-0208 Arzerra® (ofatumumab) (Intravenous)
VP-0226 Opdivo® (nivolumab) (Intravenous)
VP-0257 Yondelis® (trabectedin) (Intravenous)
VP-0268 Empliciti™ (elotuzumab) (Intravenous)
VP-0283 Sustol® (granisetron extended-release) (Subcutaneous)
VP-0317 Besponsa (inotuzumab ozogamicin) (Intravenous)
VP-0319 Kymriah (tisagenlecleucel) (Intravenous)
VP-0320 Mylotarg (gemtuzumab ozogamicin) (Intravenous)
VP-0322 Rituxan Hycela™ (rituximab and hyaluronidase human) (Subcutaneous)
VP-0333 Yescarta™ (axicabtagene ciloleucel) (Intravenous)
VP-0336 Cinvanti™ (aprepitant) (Intravenous)
VP-0363 Akynzeo® (fosnetupitant/palonosetron) (Intravenous)
VP-0482 Polivy™ (polatuzumab vedotin-piiq) (Intravenous)
VP-0503 Reblozyl® (luspatercept-aamt) (Subcutaneous)
VP-0521 Padcev™ (enfortumab vedotin-ejfv) (Intravenous)
VP-0522 Enhertu® (fam-trastuzumab deruxtecan-nxki) (Intravenous)
VP-0531 Jelmyto™ (mitomycin) (Intra-pyelocalyceal)
VP-0532 Trodelvy™ (sacituzumab govitecan-hziy) (Intravenous)
VP-0535 Darzalex Faspro™ (daratumumab and hyaluronidase-fihj) (Subcutaneous)
VP-0547 Evomela® (melphalan) (Intravenous)
VP-0550 Zepzelca™ (lurbinectedin) (Intravenous)
VP-0558 Tecartus™ (brexucabtagene autoleucel) (Intravenous)
VP-0559 Monjuvi™ (tafasitamab-cxix) (Intravenous)
VP-0561 Blenrep® (belantamab mafodotin-blmf) (Intravenous)
VP-0581 Danyelza® (naxitamab-gqgk) (Intravenous)
VP-0583 Margenza™ (margetuximab-cmkb) (Intravenous)
VP-90014 Bevacizumab: Avastin®; Mvasi™; Zirabev™ (Intravenous)
VP-90057 Trastuzumab: Herceptin®; Ogivri™; Kanjinti™; Trazimera™; Herzuma®; Ontruzant® (Intravenous)
VP-90109 Rituximab: Rituxan®, Truxima®, Ruxience® (Intravenous)